Lessons coming from a damaging gene therapy test for Duchenne muscular dystrophy

.Nature Medicine, Published online: 09 October 2024 doi:10.1038/ s41591-024-03316-9Delandistrogene moxeparvovec obtained FDA confirmation after a damaging test, which highlights the many difficulties and challenges of medicine growth in this setup.